APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antivirals

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antivirals Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchAntivirals Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Antivirals Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Antivirals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antivirals Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antivirals Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Antivirals market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antivirals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antivirals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antivirals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antivirals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antivirals include Teva Pharmaceutical Industries, Johnson & Johnson, Merck, Mylan, Gilead Sciences, GSK, AbbVie, F. Hoffmann-La Roche and Dr Reddy’s, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antivirals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antivirals, also provides the sales of main regions and countries. Of the upcoming market potential for Antivirals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antivirals sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antivirals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antivirals sales, projected growth trends, production technology, application and end-user industry.

Antivirals Segment by Company

Teva Pharmaceutical Industries

Johnson & Johnson

Merck

Mylan

Gilead Sciences

GSK

AbbVie

F. Hoffmann-La Roche

Dr Reddy’s

Cipla

Bristol-Myers-Squibb

Aurobindo Pharma

Antivirals Segment by Type

Generic

Branded

Antivirals Segment by Application

HIV

Influenza

Hepatitis

HSV

Antivirals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antivirals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antivirals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antivirals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antivirals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antivirals sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antivirals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Generic Major Manufacturers Table 3. Branded Major Manufacturers Table 4. Global Antivirals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. HIV Major Manufacturers Table 6. Influenza Major Manufacturers Table 7. Hepatitis Major Manufacturers Table 8. HSV Major Manufacturers Table 9. Antivirals Industry Trends Table 10. Antivirals Industry Drivers Table 11. Antivirals Industry Opportunities and Challenges Table 12. Antivirals Industry Restraints Table 13. Global Antivirals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Antivirals Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Antivirals Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Antivirals Revenue Market Share by Region (2021-2026) Table 17. Global Antivirals Revenue Market Share by Region (2027-2032) Table 18. Global Antivirals Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 19. Global Antivirals Sales by Region (2021-2026) & (k tons) Table 20. Global Antivirals Sales by Region (2027-2032) & (k tons) Table 21. Global Antivirals Sales Market Share by Region (2021-2026) Table 22. Global Antivirals Sales Market Share by Region (2027-2032) Table 23. Global Antivirals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Antivirals Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Antivirals Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Antivirals Sales Market Share by Manufacturers (2021-2026) Table 27. Global Antivirals Sales Price (US$/ton) of Manufacturers (2021-2026) Table 28. Global Antivirals Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Antivirals Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Antivirals Manufacturers, Product Type & Application Table 31. Global Antivirals Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Antivirals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Antivirals Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Antivirals Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Antivirals Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Antivirals Revenue Market Share by Type (2021-2026) Table 38. Global Antivirals Revenue Market Share by Type (2027-2032) Table 39. Global Antivirals Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 40. Global Antivirals Sales by Type (2021-2026) & (k tons) Table 41. Global Antivirals Sales by Type (2027-2032) & (k tons) Table 42. Global Antivirals Sales Market Share by Type (2021-2026) Table 43. Global Antivirals Sales Market Share by Type (2027-2032) Table 44. Global Antivirals Price by Type (2021-2026) & (US$/ton) Table 45. Global Antivirals Price by Type (2027-2032) & (US$/ton) Table 46. Global Antivirals Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Antivirals Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Antivirals Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Antivirals Revenue Market Share by Application (2021-2026) Table 50. Global Antivirals Revenue Market Share by Application (2027-2032) Table 51. Global Antivirals Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 52. Global Antivirals Sales by Application (2021-2026) & (k tons) Table 53. Global Antivirals Sales by Application (2027-2032) & (k tons) Table 54. Global Antivirals Sales Market Share by Application (2021-2026) Table 55. Global Antivirals Sales Market Share by Application (2027-2032) Table 56. Global Antivirals Price by Application (2021-2026) & (US$/ton) Table 57. Global Antivirals Price by Application (2027-2032) & (US$/ton) Table 58. Teva Pharmaceutical Industries Company Information Table 59. Teva Pharmaceutical Industries Business Overview Table 60. Teva Pharmaceutical Industries Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 61. Teva Pharmaceutical Industries Antivirals Product Portfolio Table 62. Teva Pharmaceutical Industries Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Antivirals Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Merck Antivirals Product Portfolio Table 72. Merck Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Mylan Antivirals Product Portfolio Table 77. Mylan Recent Development Table 78. Gilead Sciences Company Information Table 79. Gilead Sciences Business Overview Table 80. Gilead Sciences Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Gilead Sciences Antivirals Product Portfolio Table 82. Gilead Sciences Recent Development Table 83. GSK Company Information Table 84. GSK Business Overview Table 85. GSK Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. GSK Antivirals Product Portfolio Table 87. GSK Recent Development Table 88. AbbVie Company Information Table 89. AbbVie Business Overview Table 90. AbbVie Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. AbbVie Antivirals Product Portfolio Table 92. AbbVie Recent Development Table 93. F. Hoffmann-La Roche Company Information Table 94. F. Hoffmann-La Roche Business Overview Table 95. F. Hoffmann-La Roche Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. F. Hoffmann-La Roche Antivirals Product Portfolio Table 97. F. Hoffmann-La Roche Recent Development Table 98. Dr Reddy’s Company Information Table 99. Dr Reddy’s Business Overview Table 100. Dr Reddy’s Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Dr Reddy’s Antivirals Product Portfolio Table 102. Dr Reddy’s Recent Development Table 103. Cipla Company Information Table 104. Cipla Business Overview Table 105. Cipla Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Cipla Antivirals Product Portfolio Table 107. Cipla Recent Development Table 108. Bristol-Myers-Squibb Company Information Table 109. Bristol-Myers-Squibb Business Overview Table 110. Bristol-Myers-Squibb Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Bristol-Myers-Squibb Antivirals Product Portfolio Table 112. Bristol-Myers-Squibb Recent Development Table 113. Aurobindo Pharma Company Information Table 114. Aurobindo Pharma Business Overview Table 115. Aurobindo Pharma Antivirals Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 116. Aurobindo Pharma Antivirals Product Portfolio Table 117. Aurobindo Pharma Recent Development Table 118. North America Antivirals Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Antivirals Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Antivirals Sales by Type (2021-2026) & (k tons) Table 121. North America Antivirals Sales by Type (2027-2032) & (k tons) Table 122. North America Antivirals Sales Price by Type (2021-2026) & (US$/ton) Table 123. North America Antivirals Sales Price by Type (2027-2032) & (US$/ton) Table 124. North America Antivirals Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Antivirals Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Antivirals Sales by Application (2021-2026) & (k tons) Table 127. North America Antivirals Sales by Application (2027-2032) & (k tons) Table 128. North America Antivirals Sales Price by Application (2021-2026) & (US$/ton) Table 129. North America Antivirals Sales Price by Application (2027-2032) & (US$/ton) Table 130. North America Antivirals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Antivirals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Antivirals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Antivirals Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 134. North America Antivirals Sales by Country (2021-2026) & (k tons) Table 135. North America Antivirals Sales by Country (2027-2032) & (k tons) Table 136. North America Antivirals Sales Price by Country (2021-2026) & (US$/ton) Table 137. North America Antivirals Sales Price by Country (2027-2032) & (US$/ton) Table 138. United States Antivirals Revenue (2021-2032) & (US$ Million) Table 139. Canada Antivirals Revenue (2021-2032) & (US$ Million) Table 140. Mexico Antivirals Revenue (2021-2032) & (US$ Million) Table 141. Europe Antivirals Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Antivirals Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Antivirals Sales by Type (2021-2026) & (k tons) Table 144. Europe Antivirals Sales by Type (2027-2032) & (k tons) Table 145. Europe Antivirals Sales Price by Type (2021-2026) & (US$/ton) Table 146. Europe Antivirals Sales Price by Type (2027-2032) & (US$/ton) Table 147. Europe Antivirals Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Antivirals Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Antivirals Sales by Application (2021-2026) & (k tons) Table 150. Europe Antivirals Sales by Application (2027-2032) & (k tons) Table 151. Europe Antivirals Sales Price by Application (2021-2026) & (US$/ton) Table 152. Europe Antivirals Sales Price by Application (2027-2032) & (US$/ton) Table 153. Europe Antivirals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Antivirals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Antivirals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Antivirals Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 157. Europe Antivirals Sales by Country (2021-2026) & (k tons) Table 158. Europe Antivirals Sales by Country (2027-2032) & (k tons) Table 159. Europe Antivirals Sales Price by Country (2021-2026) & (US$/ton) Table 160. Europe Antivirals Sales Price by Country (2027-2032) & (US$/ton) Table 161. Germany Antivirals Revenue (2021-2032) & (US$ Million) Table 162. France Antivirals Revenue (2021-2032) & (US$ Million) Table 163. U.K. Antivirals Revenue (2021-2032) & (US$ Million) Table 164. Italy Antivirals Revenue (2021-2032) & (US$ Million) Table 165. Russia Antivirals Revenue (2021-2032) & (US$ Million) Table 166. Spain Antivirals Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Antivirals Revenue (2021-2032) & (US$ Million) Table 168. Switzerland Antivirals Revenue (2021-2032) & (US$ Million) Table 169. Sweden Antivirals Revenue (2021-2032) & (US$ Million) Table 170. Poland Antivirals Revenue (2021-2032) & (US$ Million) Table 171. China Antivirals Revenue by Type (2021-2026) & (US$ Million) Table 172. China Antivirals Revenue by Type (2027-2032) & (US$ Million) Table 173. China Antivirals Sales by Type (2021-2026) & (k tons) Table 174. China Antivirals Sales by Type (2027-2032) & (k tons) Table 175. China Antivirals Sales Price by Type (2021-2026) & (US$/ton) Table 176. China Antivirals Sales Price by Type (2027-2032) & (US$/ton) Table 177. China Antivirals Revenue by Application (2021-2026) & (US$ Million) Table 178. China Antivirals Revenue by Application (2027-2032) & (US$ Million) Table 179. China Antivirals Sales by Application (2021-2026) & (k tons) Table 180. China Antivirals Sales by Application (2027-2032) & (k tons) Table 181. China Antivirals Sales Price by Application (2021-2026) & (US$/ton) Table 182. China Antivirals Sales Price by Application (2027-2032) & (US$/ton) Table 183. Asia Antivirals Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Antivirals Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Antivirals Sales by Type (2021-2026) & (k tons) Table 186. Asia Antivirals Sales by Type (2027-2032) & (k tons) Table 187. Asia Antivirals Sales Price by Type (2021-2026) & (US$/ton) Table 188. Asia Antivirals Sales Price by Type (2027-2032) & (US$/ton) Table 189. Asia Antivirals Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Antivirals Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Antivirals Sales by Application (2021-2026) & (k tons) Table 192. Asia Antivirals Sales by Application (2027-2032) & (k tons) Table 193. Asia Antivirals Sales Price by Application (2021-2026) & (US$/ton) Table 194. Asia Antivirals Sales Price by Application (2027-2032) & (US$/ton) Table 195. Asia Antivirals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Antivirals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Antivirals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Antivirals Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 199. Asia Antivirals Sales by Country (2021-2026) & (k tons) Table 200. Asia Antivirals Sales by Country (2027-2032) & (k tons) Table 201. Asia Antivirals Sales Price by Country (2021-2026) & (US$/ton) Table 202. Asia Antivirals Sales Price by Country (2027-2032) & (US$/ton) Table 203. Japan Antivirals Revenue (2021-2032) & (US$ Million) Table 204. South Korea Antivirals Revenue (2021-2032) & (US$ Million) Table 205. India Antivirals Revenue (2021-2032) & (US$ Million) Table 206. Australia Antivirals Revenue (2021-2032) & (US$ Million) Table 207. Taiwan Antivirals Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Antivirals Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Antivirals Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Antivirals Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Antivirals Sales by Type (2021-2026) & (k tons) Table 212. SAMEA Antivirals Sales by Type (2027-2032) & (k tons) Table 213. SAMEA Antivirals Sales Price by Type (2021-2026) & (US$/ton) Table 214. SAMEA Antivirals Sales Price by Type (2027-2032) & (US$/ton) Table 215. SAMEA Antivirals Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Antivirals Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Antivirals Sales by Application (2021-2026) & (k tons) Table 218. SAMEA Antivirals Sales by Application (2027-2032) & (k tons) Table 219. SAMEA Antivirals Sales Price by Application (2021-2026) & (US$/ton) Table 220. SAMEA Antivirals Sales Price by Application (2027-2032) & (US$/ton) Table 221. SAMEA Antivirals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Antivirals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Antivirals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Antivirals Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 225. SAMEA Antivirals Sales by Country (2021-2026) & (k tons) Table 226. SAMEA Antivirals Sales by Country (2027-2032) & (k tons) Table 227. SAMEA Antivirals Sales Price by Country (2021-2026) & (US$/ton) Table 228. SAMEA Antivirals Sales Price by Country (2027-2032) & (US$/ton) Table 229. Brazil Antivirals Revenue (2021-2032) & (US$ Million) Table 230. Argentina Antivirals Revenue (2021-2032) & (US$ Million) Table 231. Chile Antivirals Revenue (2021-2032) & (US$ Million) Table 232. Colombia Antivirals Revenue (2021-2032) & (US$ Million) Table 233. Peru Antivirals Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Antivirals Revenue (2021-2032) & (US$ Million) Table 235. Israel Antivirals Revenue (2021-2032) & (US$ Million) Table 236. UAE Antivirals Revenue (2021-2032) & (US$ Million) Table 237. Turkey Antivirals Revenue (2021-2032) & (US$ Million) Table 238. Iran Antivirals Revenue (2021-2032) & (US$ Million) Table 239. Egypt Antivirals Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Antivirals Distributors List Table 243. Antivirals Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Antivirals Image Figure 2. Global Antivirals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antivirals Market Size Share 2021 VS 2025 VS 2032 Figure 4. Generic Image Figure 5. Branded Image Figure 6. Global Antivirals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antivirals Market Size Share 2021 VS 2025 VS 2032 Figure 8. HIV Image Figure 9. Influenza Image Figure 10. Hepatitis Image Figure 11. HSV Image Figure 12. Global Antivirals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Antivirals Revenue (2021-2032) & (US$ Million) Figure 14. Global Antivirals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Antivirals Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Antivirals Revenue Market Share by Region (2021-2032) Figure 17. Global Antivirals Sales (2021-2032) & (k tons) Figure 18. Global Antivirals Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 19. Global Antivirals Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Antivirals Sales YoY (2021-2032) & (k tons) Figure 21. Europe Antivirals Sales YoY (2021-2032) & (k tons) Figure 22. China Antivirals Sales YoY (2021-2032) & (k tons) Figure 23. Asia (Excluding China) Antivirals Sales YoY (2021-2032) & (k tons) Figure 24. South America, Middle East and Africa Antivirals Sales YoY (2021-2032) & (k tons) Figure 25. Global Antivirals Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Antivirals Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Antivirals Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Antivirals Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Antivirals Revenue Market Share by Type (2021-2032) Figure 31. Global Antivirals Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 32. Global Antivirals Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Antivirals Sales Market Share by Type (2021-2032) Figure 34. Global Antivirals Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Antivirals Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Antivirals Revenue Market Share by Application (2021-2032) Figure 37. Global Antivirals Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 38. Global Antivirals Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Antivirals Sales Market Share by Application (2021-2032) Figure 40. North America Antivirals Revenue Share by Type (2021-2032) Figure 41. North America Antivirals Sales Share by Type (2021-2032) Figure 42. North America Antivirals Revenue Share by Application (2021-2032) Figure 43. North America Antivirals Sales Share by Application (2021-2032) Figure 44. North America Antivirals Revenue Share by Country (2021-2032) Figure 45. North America Antivirals Sales Share by Country (2021-2032) Figure 46. Europe Antivirals Revenue Share by Type (2021-2032) Figure 47. Europe Antivirals Sales Share by Type (2021-2032) Figure 48. Europe Antivirals Revenue Share by Application (2021-2032) Figure 49. Europe Antivirals Sales Share by Application (2021-2032) Figure 50. Europe Antivirals Revenue Share by Country (2021-2032) Figure 51. Europe Antivirals Sales Share by Country (2021-2032) Figure 52. China Antivirals Revenue Share by Type (2021-2032) Figure 53. China Antivirals Sales Share by Type (2021-2032) Figure 54. China Antivirals Revenue Share by Application (2021-2032) Figure 55. China Antivirals Sales Share by Application (2021-2032) Figure 56. Asia Antivirals Revenue Share by Type (2021-2032) Figure 57. Asia Antivirals Sales Share by Type (2021-2032) Figure 58. Asia Antivirals Revenue Share by Application (2021-2032) Figure 59. Asia Antivirals Sales Share by Application (2021-2032) Figure 60. Asia Antivirals Revenue Share by Country (2021-2032) Figure 61. Asia Antivirals Sales Share by Country (2021-2032) Figure 62. SAMEA Antivirals Revenue Share by Type (2021-2032) Figure 63. SAMEA Antivirals Sales Share by Type (2021-2032) Figure 64. SAMEA Antivirals Revenue Share by Application (2021-2032) Figure 65. SAMEA Antivirals Sales Share by Application (2021-2032) Figure 66. SAMEA Antivirals Revenue Share by Country (2021-2032) Figure 67. SAMEA Antivirals Sales Share by Country (2021-2032) Figure 68. Antivirals Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Antivirals Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Generic
  • Branded
Applications
  • HIV
  • Influenza
  • Hepatitis
  • HSV
Companies covered
  • Teva Pharmaceutical Industries
  • Johnson & Johnson
  • Merck
  • Mylan
  • Gilead Sciences
  • GSK
  • AbbVie
  • F. Hoffmann-La Roche
  • Dr Reddy’s
  • Cipla
  • Bristol-Myers-Squibb
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antivirals Market by Type
  3. 1.2.1 Global Antivirals Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Generic
  5. 1.2.3 Branded
  6. 1.3 Antivirals Market by Application
  7. 1.3.1 Global Antivirals Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 HIV
  9. 1.3.3 Influenza
  10. 1.3.4 Hepatitis
  11. 1.3.5 HSV
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Antivirals Market Dynamics
  1. 2.1 Antivirals Industry Trends
  2. 2.2 Antivirals Industry Drivers
  3. 2.3 Antivirals Industry Opportunities and Challenges
  4. 2.4 Antivirals Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antivirals Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antivirals Revenue by Region
  3. 3.2.1 Global Antivirals Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antivirals Revenue by Region (2021-2026)
  5. 3.2.3 Global Antivirals Revenue by Region (2027-2032)
  6. 3.2.4 Global Antivirals Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antivirals Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antivirals Sales by Region
  9. 3.4.1 Global Antivirals Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antivirals Sales by Region (2021-2026)
  11. 3.4.3 Global Antivirals Sales by Region (2027-2032)
  12. 3.4.4 Global Antivirals Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antivirals Revenue by Manufacturers
  2. 4.1.1 Global Antivirals Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antivirals Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antivirals Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antivirals Sales by Manufacturers
  6. 4.2.1 Global Antivirals Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antivirals Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antivirals Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antivirals Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antivirals Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antivirals Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antivirals Manufacturers, Product Type & Application
  13. 4.7 Global Antivirals Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antivirals Market CR5 and HHI
  16. 4.8.2 2025 Antivirals Tier 1, Tier 2, and Tier 3
5 Antivirals Market by Type
  1. 5.1 Global Antivirals Revenue by Type
  2. 5.1.1 Global Antivirals Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antivirals Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antivirals Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antivirals Sales by Type
  6. 5.2.1 Global Antivirals Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antivirals Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Antivirals Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antivirals Price by Type
6 Antivirals Market by Application
  1. 6.1 Global Antivirals Revenue by Application
  2. 6.1.1 Global Antivirals Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antivirals Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antivirals Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antivirals Sales by Application
  6. 6.2.1 Global Antivirals Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antivirals Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Antivirals Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antivirals Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries
  2. 7.1.1 Teva Pharmaceutical Industries Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Antivirals Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Antivirals Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Antivirals Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Antivirals Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Gilead Sciences
  26. 7.5.1 Gilead Sciences Company Information
  27. 7.5.2 Gilead Sciences Business Overview
  28. 7.5.3 Gilead Sciences Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Gilead Sciences Antivirals Product Portfolio
  30. 7.5.5 Gilead Sciences Recent Developments
  31. 7.6 GSK
  32. 7.6.1 GSK Company Information
  33. 7.6.2 GSK Business Overview
  34. 7.6.3 GSK Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GSK Antivirals Product Portfolio
  36. 7.6.5 GSK Recent Developments
  37. 7.7 AbbVie
  38. 7.7.1 AbbVie Company Information
  39. 7.7.2 AbbVie Business Overview
  40. 7.7.3 AbbVie Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AbbVie Antivirals Product Portfolio
  42. 7.7.5 AbbVie Recent Developments
  43. 7.8 F. Hoffmann-La Roche
  44. 7.8.1 F. Hoffmann-La Roche Company Information
  45. 7.8.2 F. Hoffmann-La Roche Business Overview
  46. 7.8.3 F. Hoffmann-La Roche Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 F. Hoffmann-La Roche Antivirals Product Portfolio
  48. 7.8.5 F. Hoffmann-La Roche Recent Developments
  49. 7.9 Dr Reddy’s
  50. 7.9.1 Dr Reddy’s Company Information
  51. 7.9.2 Dr Reddy’s Business Overview
  52. 7.9.3 Dr Reddy’s Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Dr Reddy’s Antivirals Product Portfolio
  54. 7.9.5 Dr Reddy’s Recent Developments
  55. 7.10 Cipla
  56. 7.10.1 Cipla Company Information
  57. 7.10.2 Cipla Business Overview
  58. 7.10.3 Cipla Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cipla Antivirals Product Portfolio
  60. 7.10.5 Cipla Recent Developments
  61. 7.11 Bristol-Myers-Squibb
  62. 7.11.1 Bristol-Myers-Squibb Company Information
  63. 7.11.2 Bristol-Myers-Squibb Business Overview
  64. 7.11.3 Bristol-Myers-Squibb Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bristol-Myers-Squibb Antivirals Product Portfolio
  66. 7.11.5 Bristol-Myers-Squibb Recent Developments
  67. 7.12 Aurobindo Pharma
  68. 7.12.1 Aurobindo Pharma Company Information
  69. 7.12.2 Aurobindo Pharma Business Overview
  70. 7.12.3 Aurobindo Pharma Antivirals Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Aurobindo Pharma Antivirals Product Portfolio
  72. 7.12.5 Aurobindo Pharma Recent Developments
8 North America
  1. 8.1 North America Antivirals Market Size by Type
  2. 8.1.1 North America Antivirals Revenue by Type (2021-2032)
  3. 8.1.2 North America Antivirals Sales by Type (2021-2032)
  4. 8.1.3 North America Antivirals Price by Type (2021-2032)
  5. 8.2 North America Antivirals Market Size by Application
  6. 8.2.1 North America Antivirals Revenue by Application (2021-2032)
  7. 8.2.2 North America Antivirals Sales by Application (2021-2032)
  8. 8.2.3 North America Antivirals Price by Application (2021-2032)
  9. 8.3 North America Antivirals Market Size by Country
  10. 8.3.1 North America Antivirals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antivirals Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antivirals Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Antivirals Market Size by Type
  2. 9.1.1 Europe Antivirals Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antivirals Sales by Type (2021-2032)
  4. 9.1.3 Europe Antivirals Price by Type (2021-2032)
  5. 9.2 Europe Antivirals Market Size by Application
  6. 9.2.1 Europe Antivirals Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antivirals Sales by Application (2021-2032)
  8. 9.2.3 Europe Antivirals Price by Application (2021-2032)
  9. 9.3 Europe Antivirals Market Size by Country
  10. 9.3.1 Europe Antivirals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antivirals Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antivirals Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Antivirals Market Size by Type
  2. 10.1.1 China Antivirals Revenue by Type (2021-2032)
  3. 10.1.2 China Antivirals Sales by Type (2021-2032)
  4. 10.1.3 China Antivirals Price by Type (2021-2032)
  5. 10.2 China Antivirals Market Size by Application
  6. 10.2.1 China Antivirals Revenue by Application (2021-2032)
  7. 10.2.2 China Antivirals Sales by Application (2021-2032)
  8. 10.2.3 China Antivirals Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antivirals Market Size by Type
  2. 11.1.1 Asia Antivirals Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antivirals Sales by Type (2021-2032)
  4. 11.1.3 Asia Antivirals Price by Type (2021-2032)
  5. 11.2 Asia Antivirals Market Size by Application
  6. 11.2.1 Asia Antivirals Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antivirals Sales by Application (2021-2032)
  8. 11.2.3 Asia Antivirals Price by Application (2021-2032)
  9. 11.3 Asia Antivirals Market Size by Country
  10. 11.3.1 Asia Antivirals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antivirals Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antivirals Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antivirals Market Size by Type
  2. 12.1.1 SAMEA Antivirals Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antivirals Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antivirals Price by Type (2021-2032)
  5. 12.2 SAMEA Antivirals Market Size by Application
  6. 12.2.1 SAMEA Antivirals Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antivirals Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antivirals Price by Application (2021-2032)
  9. 12.3 SAMEA Antivirals Market Size by Country
  10. 12.3.1 SAMEA Antivirals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antivirals Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antivirals Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antivirals Value Chain Analysis
  2. 13.1.1 Antivirals Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antivirals Production Mode & Process
  6. 13.2 Antivirals Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antivirals Distributors
  9. 13.2.3 Antivirals Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst